Table 1.
Clinical, laboratory and anthropometric findings (means ± standard deviations) of patients and controls.
| Patients (n = 50) | Controls (n = 28) | |
|---|---|---|
| Age (years) | 65.42 ± 9.59 | 62.07 ± 8.34 |
| BMI (kg/m2) | 27.31 ± 4.29 | 28.63 ± 4.84 |
| BMD (T-score)* | −3.09 ± 0.66 | −0.23 ± 1.13 |
| PTH (pg/mL) | 64.93 ± 22.69 | 67.97 ± 16.26 |
| ALP (U/L) | 123.26 ± 62.36 | 103.57 ± 25.76 |
| CTX (pg/mL)* | 429.01 ± 273.58 | 290.93 ± 180.57 |
| P1NP (ng/ml) | 21.10 ± 11.82 | 24.37 ± 14.35 |
| 1,25(OH)2-D3(pg/mL) | 19.12 ± 8.98 | 22.37 ± 5.89 |
| Ca++(mg/dl) | 9.16 ± 0.77 | 7.14 ± 3.58 |
| Fractured subjects (number)* | 14 | 0 |
Legend: Body mass index (BMI); Bone mineral density (BMD); Parathyroid hormone (PTH); Alkaline phosphatase (ALP); C-terminal telopeptide of type 1 collagen (CTX); N-terminal propeptide of type 1 procollagen (P1NP); 1α,25-dihydroxyvitamin-D3 (1,2 S(OH)2-D3); Serum calcium (Ca++).
*Statistically significant difference between patients and controls (p < 0.01).